NIH CFAR Administrative Supplements

The DC CFAR promotes periodic NIH CFAR Administrative Supplement opportunities to our membership when we are made aware of them. These supplements are offered by the NIH to spur research in high priority areas.

The center communicates open requests for applications through weekly member emails. Become a member of the DC CFAR to learn more about NIH CFAR Administrative Supplements.

DC CFAR investigators have been very successful in competing for NIH CFAR Administrative Supplements to date. A listing of all currently and previously funded investigators and abstracts of their projects are provided.

2016 Awards

Real-time Phylodynamic Analysis of HIV in Washington, DC

Amanda Castel, MD, MPH, and Marcos Perez-Losada, PhD, MS have received an NIH CFAR Administrative Supplement to study HIV transmission patterns in Washington, DC to better identify which subpopulations and geographic areas are at highest risk for transmission and potential spread.

2015 Awards

Impairment of ABCA1 glycosylation as a pathogenic mechanism in Nef-induced atherosclerosis

Radoslav Goldman, PhD has received an NIH CFAR Administrative supplement to characterize the role of glycosylation in ABCA1 functionality. ABCA1 is a key anti-atherogenic factor responsible for HDL production and cholesterol efflux. ABCA1 is targeted by HIV-1 Nef, which impairs ABCA1 maturation. Maturation of ABCA1 is tightly linked to its glycosylation, but detailed characterization of the role of glycosylation in ABCA1 functionality has not been done. Dr. Radoslav seeks to close this gap in our knowledge, providing the basis for future therapeutic efforts.

Advancing Pre-exposure Prophylaxis (PrEP) Delivery among Black MSM in the District of Columbia

Marc Siegel, MD has received an NIH CFAR Administrative supplement to study whether a novel culturally competent clinic intervention can increase the uptake of pre-exposure prophylaxis (PrEP) to prevent HIV infection in black and young men who have sex with men. This population are among the only US populations to have recently experienced a significant increase in the number of incident HIV infections.

2013 Awards

The Impact of Sexual Violence on the Systemic and Female Genital Tract

Mimi Ghosh, PhD, MS has received a NIH CFAR Administrative Supplement to study the relationship between sexual violence and inflammatory response in women from Washington, DC where there is a high prevalence of HIV. Dr. Ghosh is an Assistant Professor in the Department of Epidemiology and Biostatistics at the George Washington University.

Expanding Multiparametric Flow Cytometry Capacity for the DC D-CFAR

Douglas F. Nixon, MD, PhD has been awarded a NIH CFAR Administrative Supplement to improve the multiparmetric flow cytometry capacity for the DC D-CFAR Dr. Nixon is the Walter G. Ross Professor and Chair of Microbiology, Immunology, and Tropical Medicine in the School of Medicine and Health Sciences at the George Washington University.

2014 CFAR/APC ECHPP Meeting

Alan E. Greenberg, MD, MPH has been awarded NIH CFAR Administrative Supplement to host the 2014 ECHPP meeting. Dr. Greenberg is the Director of the DC D-CFAR and a Professor and Chair in the Department of Epidemiology and Biostatistics at the George Washington University.

Using Surveillance Data to Drive Cascade-Related Community-Based HIV

Amanda D. Castel, MD, MPH has been awarded a NIH CFAR Administrative Supplement to implement a pilot community-based mobile HIV intervention through ECHPP-3. Dr. Castel is an Assistant Professor in the Department of Epidemiology and Biostatistics at the George Washington University.

2012 Awards

CFAR ECHPP Initiative

Alan E. Greenberg, MD, MPH has been awarded a second parent award for the ECHPP Initiative. Dr. Greenberg is the Director of the DC D-CFAR and a Professor and Chair in the Department of Epidemiology and Biostatistics at the George Washington University.

Targeting Protein Phosphatase-1 for Activation of Latent HIV-1 Provirus

Sergei Nekhai, PhD has received a NIH CFAR Administrative Supplement to study novel therapeutic approaches for latent HIV provirus. Dr. Nekhai is an Associate Professor in the Department of Medicine at Howard University.

ECHPP Initiative

Amanda D. Castel, MD, MPH has been awarded NIH CFAR Administrative Supplemental funding to continue work with the Department of Health in the district. Dr. Castel is an Assistant Professor in the Department of Epidemiology and Biostatistics at the George Washington University.

2011 Awards

Natural Product Derived CXCR4/CCR2 Dual-targeted Fusion Inhibitors

X. Simon Wang, PhD has received a NIH CFAR Administrative Supplement to conduct virtual screening of potential CXCR4/CCR2 dual targeting fusion inhibitors. Dr. Wang is an Assistant Professor in the Department of Pharmaceutical Sciences at Howard University.

Microvascular Endothelial Function and Aging in Patients with HIV/AIDS

Dan Wang, MD, PhD has been awarded a NIH CFAR Administrative Supplement to collect preliminary data on microvascular function and perivascular adipose tissue signaling in older adults. Dr. Wang is a Research Associate Professor at the Georgetown University School of Medicine.

Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS

Alan E. Greenberg, MD, MPH has been awarded a parent award for the ECHPP Initiative. Dr. Greenberg is the Director of the DC D-CFAR and a Professor and Chair in the Department of Epidemiology and Biostatistics at the George Washington University.

GWU Support of ECHPP Initiative

Amanda D. Castel, MD, MPH has been awarded NIH CFAR Administrative Supplemental funding to evaluate current DC linkage to care and assess the feasibility of PrEP in the district. Dr. Castel is an Assistant Professor in the Department of Epidemiology and Biostatistics at the George Washington University.

Microvascular Targeting Drug (ARV)-Loaded Multifunctional Nanoparticles to M Cells Overlaying GALT (HIV-1 Reservoir)

Emmanuel Akala, PhD, RpH, MSc was awarded a NIH CFAR Administrative Supplement for his work utilzing nanoparticles to deliver antiretroviral drugs. Dr. Akala is an Associate Professor of Pharmaceutical Sciences at Howard University.

Contact

Brandi Robinson
Scientific Specialist
202-994-4730
bnrobin@gwu.edu

Local Events

June
07
Wednesday
12:00pm—1:00pm